"Please let us know if you think "it may be"."
I've already said it may or it may not be - I don't really know.
There's lots about this company, including the Aruda affair, the conference-gate affair, the big Pharma type remuneration and the steadfast refusal to move to a stock exchange that makes me suspicious.
On the other hand, it might be as wonderful as some claim.
But it's indisputable that there are two separate types of risk with this stock - the risk of being listed and quoted on the developed world's sleaziest stock venue, the US OTC, and then the risk associated with any development stage biopharma that the products may not perform as expected.
For that reason I think it's mistaken to present CTIX as some kind of cast-iron guaranteed slam-dunk that will make all its shareholders rich beyond their wildest dreams.
I've seen that story way too often on the OTC, and it never once turned out to be true.
News 
Market Data 
Discover 
